Document is current
Any future updates will be listed below
-
Authors
Michels, Julia D.
Meis, Jan
Sturm, Noemi
Bornitz, Florian
von Schumann, Selina
Weis, Aline
Neetz, Benjamin
Bentner, Martina
Forstner, Johanna
Litke, Nicola
Wensing, Michel
Erdmann, Stella
Grobe, Thomas
Frerk, Timm
Kempa, Axel
Neurohr, Claus
Schneider, Armin
Müller, Michael
Herth, Felix J. F.
Szecsenyi, Joachim
Trudzinski, Franziska C.
,
Trudzinski, Franziska Christina
Iberl, Gabriele
Müller, Beatrice
Biehler, Elena
Fleischhhauer, Thomas
Fuchs, Gerhard
Qreini, Markus
Schubert-Haack, Janina
Klingenberg, Anja
Kempa, Alex
Joves, Biljana
Rheinhold, Andreas
Ghiani, Alessandro
Lutz, Nina
Walcher, Swenja
Tsitouras, Konstantinos
Paderewska, Joanna
Briese, Selina
Andritschky, Christoph
Gehrig, Patrick
Sugg, Joachim
Hirschmann, Susanne
Britsch, Simone
Straub, Christa
Jabbour, Claude
Hahn, Michael
Krebs, Jörg
Graf, Peter-Tobias
Denzer, Petra
Fiedler, Mascha O.
Bomeken, Miriane
Stier, Sebastian
Terboven, Tom
Merle, Uta
Regula, Jens
Müller, Jens
Oltmanns, Ute
Hennersdorf, Marcus
Satir, Neslihan
Borst, Mathias
Mayer, Brigitte
Reikow, Wolfgang
Kredel, Markus
Frey, Konstantin
Wolff, Holger
Seidlitz, Florian
Bientzle, Stefanie
Nohé, Boris
Allgäuer, Sebastian
Schöpp, Alexej
Schlegel, Christoph
Hübner, Imke
Kuzniar, Andrezj
Häberle, Helene
Riessen, Reimer
Schempf, Benjamin
Rebenschütz, Ingo
Straub, Andreas
Kollum, Marc
Winter, Markus
Hartveg, Paul
Junginger, Andreas
Beck, Helmut
Vogel, Mathias
-
Funding
Funding for this research was provided by:
the Federal Joint Committee (01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023, 01NVF19023)
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 30 January 2023
Accepted: 14 March 2023
First Online: 30 March 2023
Declarations
:
: The study protocol version 1.0 of the PRiVENT-study was first approved by the ethics committee of the Medical Faculty Heidelberg prior to the start of the study (S-352/2018) on 18<sup>th</sup> September 2020, version 1.4. was approved on 21<sup>st</sup> May 2021 by the responsible ethics committee of the Medical Faculty Heidelberg as well as the ethics committee of Baden-Württemberg’s Chamber of Physicians.Patients who fulfil the eligibility criteria and have given informed consent to participate in the study can be included. As invasively ventilated patients are usually not capable of giving consent, their legal guardian will be informed instead.The PRiVENT Advisory Board, consisting of physicians across Germany, will supervise the study, meeting regularly every 3–4 months to review processes and recruitment. The study will be conducted following the International Conference on Harmonisation Guideline for Good Clinical Practice and complies with the Declaration of Helsinki.
: Not required.
: Joachim Szecsenyi holds stock of the aQua Institut. Other authors declare none.
